Opportunity Information: Apply for PAR 12 290
Apply for PAR 12 290
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Revisions for Early Stage Development of Informatics Technology (P01)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.396 Cancer Biology Research.
- This funding opportunity was created on Aug 12, 2013 and posted on Sep 19, 2012.
- Applicants must submit their applications by Aug 12, 2013. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $150,000.00 in funding.
- Eligible applicants include: Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses Special district governments Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Public housing authorities/Indian housing authorities County governments Independent school districts Native American tribal governments (Federally recognized) Private institutions of higher education City or township governments Public and State controlled institutions of higher education State governments Others (see text field entitled Additional Information on Eligibility for clarification).
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Asian American Native American Pacific Islander Serving Institutions (AANAPISISs) Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The grant opportunity titled "Revisions for Early Stage Development of Informatics Technology (P01)" (Funding Opportunity Number PAR 12 290) is a National Institutes of Health initiative, led through the National Cancer Institute (NCI), that specifically invites competing revisions to projects that are already funded under the NCI P01 program project mechanism. In other words, it is not a standalone solicitation for brand-new P01s; it is designed for current NCI P01 awardees who want to propose a significant, revised expansion of their existing, funded program in order to develop early-stage, enabling informatics technologies that can strengthen cancer research.
The main goal is technology development that improves how cancer research data and knowledge are acquired, managed, analyzed, and shared. This sits under NCI's Informatics Technology for Cancer Research (ITCR) Initiative, which emphasizes building practical, innovative computational and informatics approaches that can help cancer researchers move faster from raw data to usable knowledge and, ultimately, to clinical impact. A key theme is interdisciplinary collaboration, meaning the program expects teams that can bridge domains such as cancer biology and medicine, computer science, informatics, data engineering, and related fields, with the intent of producing tools or platforms that meaningfully enable new research capabilities rather than simply applying existing methods.
A critical boundary in this FOA is that applications focused only on data processing/analysis or purely mathematical and statistical modeling are not considered responsive if they do not include new technology development. The emphasis is on creating or advancing informatics technologies themselves, not solely using analytics to answer scientific questions. In practical terms, the competitive revision should propose a technology-oriented expansion of the parent P01 that results in new or improved computational infrastructure, methods, or systems that can be disseminated and used by the broader cancer research community.
Administratively, this is a discretionary grant opportunity in the health and education-related funding activity categories, listed under CFDA 93.396 (Cancer Biology Research). There is no cost sharing or matching requirement stated. The posted date for the opportunity was September 19, 2012, with key dates in the record indicating an original closing date of June 18, 2015, a current closing date of August 12, 2013, and an archive date of September 12, 2013. The award ceiling shown in the summary data is $150,000, though applicants typically need to confirm budget limits and other constraints directly in the full FOA text because NIH opportunities often include nuanced budget guidance based on scope, justification, and the parent award structure.
Eligibility is broad in the sense that many organization types are listed as eligible applicants, including public and private institutions of higher education, nonprofit organizations (including 501(c)(3) entities and certain nonprofits without 501(c)(3) status), for-profit organizations (including small businesses), state and local governments, tribal governments and tribal organizations, public housing authorities, independent school districts, and various specialized institution categories such as HBCUs, Hispanic-serving institutions, AANAPISIs, TCCUs, Alaska Native and Native Hawaiian-serving institutions, faith-based or community-based organizations, U.S. territories or possessions, and even non-U.S. (foreign) entities and regional organizations. Even with this broad list, the practical gating factor is that the FOA is specifically for revisions from currently funded NCI P01 program projects, so the applicant organization must already hold the relevant active P01 award that the revision would modify.
For applicants or administrators trying to locate the full requirements, the announcement points to the NIH Grants Guide posting at http://grants.nih.gov/grants/guide/pa-files/PAR-12-290.html (as written in the source). For technical access issues, the contact listed is the NIH Office of Extramural Research (OER) webmaster at FBOWebmaster@OD.NIH.GOV, which is presented as the point of contact for problems accessing or linking to the funding announcement online.
Frequently Asked Questions (FAQs)
1) What is the official title and funding opportunity number for this grant?
The opportunity is titled "Revisions for Early Stage Development of Informatics Technology (P01)" and the Funding Opportunity Number is PAR 12 290.
2) Which agency and NIH Institute are associated with this opportunity?
This is a National Institutes of Health (NIH) initiative led through the National Cancer Institute (NCI).
3) Is this a solicitation for brand-new P01 applications?
No. This opportunity specifically invites competing revisions to projects that are already funded under the NCI P01 program project mechanism. It is designed for current NCI P01 awardees proposing a significant, revised expansion of an existing funded program.
4) What type of application is being requested?
The FOA invites competing revisions (i.e., revision applications) to existing NCI P01 program projects, rather than new standalone P01 proposals.
5) What is the main purpose of the proposed revision?
The revision should propose a technology-oriented expansion of the parent NCI P01 aimed at developing early-stage, enabling informatics technologies that strengthen cancer research.
6) What kinds of improvements is the FOA trying to enable for cancer research?
The stated goal is technology development that improves how cancer research data and knowledge are acquired, managed, analyzed, and shared.
7) How does this relate to the NCI Informatics Technology for Cancer Research (ITCR) Initiative?
The opportunity sits under NCI's Informatics Technology for Cancer Research (ITCR) Initiative, which emphasizes practical and innovative computational and informatics approaches that help cancer researchers move from raw data to usable knowledge and, ultimately, clinical impact.
8) What is the emphasis: doing cancer research analyses, or building technology?
The emphasis is on creating or advancing informatics technologies themselves. Applications that focus only on data processing/analysis or purely mathematical and statistical modeling are not considered responsive if they do not include new technology development.
9) What does "not responsive" mean in the context of this FOA?
Based on the description provided, applications that are limited to data processing/analysis or purely mathematical/statistical modeling, without new informatics technology development, are described as not responsive to the FOA's intent.
10) What kinds of projects does the FOA appear to encourage?
The FOA highlights interdisciplinary collaboration and expects teams that bridge cancer biology/medicine with areas like computer science, informatics, data engineering, and related fields, with an aim to produce tools or platforms that enable new research capabilities and can be disseminated for broader use.
11) Who is the intended applicant community?
Practically, the intended applicants are current NCI P01 awardees seeking to submit a competing revision to an active NCI P01 program project in order to expand it with early-stage informatics technology development.
12) Does the eligibility list mean any organization can apply?
Many organization types are listed as eligible (including universities, nonprofits, for-profits, governments, tribal entities, U.S. territories, and foreign entities), but the key gating factor is that the application must be a competing revision to a currently funded NCI P01 award. So the applicant organization must already hold the relevant active NCI P01 award that would be revised.
13) Are non-U.S. (foreign) entities mentioned as eligible?
Yes. The eligibility list includes non-U.S. (foreign) entities and regional organizations; however, the FOA still hinges on submitting a revision to an existing, currently funded NCI P01 program project.
14) What funding activity categories are associated with this opportunity?
The opportunity is described as a discretionary grant in the health and education-related funding activity categories.
15) What CFDA program is referenced?
The listing references CFDA 93.396 (Cancer Biology Research).
16) Is cost sharing or matching required?
No cost sharing or matching requirement is stated in the information provided.
17) What is the award ceiling shown in the summary information?
The award ceiling shown is $150,000.
18) Should applicants rely only on the summary ceiling when planning a budget?
No. The information provided notes that applicants typically need to confirm budget limits and constraints in the full FOA text, since NIH opportunities often include nuanced budget guidance based on scope, justification, and the parent award structure.
19) What are the key dates mentioned?
The posted date is September 19, 2012. The record indicates an original closing date of June 18, 2015, a current closing date of August 12, 2013, and an archive date of September 12, 2013.
20) Where can the full NIH Grants Guide announcement be found?
The announcement points to: http://grants.nih.gov/grants/guide/pa-files/PAR-12-290.html
21) Who is listed as the contact for technical access or linking problems?
For technical access issues, the contact listed is the NIH Office of Extramural Research (OER) webmaster at FBOWebmaster@OD.NIH.GOV.
22) What is the overall "bottom line" requirement to be a fit for this FOA?
The project must be a competing revision to an already funded NCI P01 program project, and the proposed expansion must be centered on early-stage development of enabling informatics technology (not analysis-only work) that can strengthen cancer research and be broadly useful.
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Education Health
Next opportunity: U.S. Department of Education and U.S. Department of Health and Human Services Race to the Top Early Learning Challenge Phase 2 CFDA Number 84.412A
Previous opportunity: Revisions for Early Stage Development of Informatics Technology (U01)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 12 290
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 12 290) also looked into and applied for these:
| Funding Opportunity |
|---|
| Research Answers to NCIs Provocative Questions Group A (R01) Apply for RFA CA 12 015 Funding Number: RFA CA 12 015 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Research Answers to NCIs Provocative Questions Group A (R21) Apply for RFA CA 12 016 Funding Number: RFA CA 12 016 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Research Answers to NCIs Provocative Questions Group B (R01) Apply for RFA CA 12 017 Funding Number: RFA CA 12 017 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Research Answers to NCIs Provocative Questions Group B (R21) Apply for RFA CA 12 018 Funding Number: RFA CA 12 018 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Research Answers to NCIs Provocative Questions Group C (R01) Apply for RFA CA 12 019 Funding Number: RFA CA 12 019 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Research Answers to NCIs Provocative Questions Group C (R21) Apply for RFA CA 12 020 Funding Number: RFA CA 12 020 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Research Answers to NCIs Provocative Questions Group D (R01) Apply for RFA CA 12 021 Funding Number: RFA CA 12 021 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Research Answers to NCIs Provocative Questions Group D (R21) Apply for RFA CA 12 022 Funding Number: RFA CA 12 022 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Specialized Programs of Research Excellence (SPOREs) in Human Cancer for Years 2013 and 2014 (P50) Apply for PAR 12 296 Funding Number: PAR 12 296 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Drug Abuse Aspects of HIV/AIDS (R01) Apply for PA 12 293 Funding Number: PA 12 293 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Drug Abuse Aspects of HIV/AIDS (R03) Apply for PA 12 294 Funding Number: PA 12 294 Agency: National Institutes of Health Category: Education Health Funding Amount: $50,000 |
| Drug Abuse Aspects of HIV/AIDS (R21) Apply for PA 12 295 Funding Number: PA 12 295 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Mechanism for Time Sensitive Drug Abuse Research (R21) Apply for PAR 12 297 Funding Number: PAR 12 297 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Cancer Center Support Grants (CCSGs) for NCI designated Cancer Centers (P30) Apply for PAR 12 298 Funding Number: PAR 12 298 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| FY 2013 American Schools and Hospitals Abroad (ASHA) Program Worldwide Apply for APS ASHA 13 000001 Funding Number: APS ASHA 13 000001 Agency: Agency for International Development Category: Education Health Funding Amount: $2,000,000 |
| NLM Grants for Scholarly Works in Biomedicine and Health (G13) Apply for PAR 13 014 Funding Number: PAR 13 014 Agency: National Institutes of Health Category: Education Health Funding Amount: $50,000 |
| Prescription Drug Abuse (R01) Apply for PA 13 015 Funding Number: PA 13 015 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Prescription Drug Abuse (R21) Apply for PA 13 016 Funding Number: PA 13 016 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Early Stage Innovative Molecular Analysis Technology Development for Cancer Research (R21) Apply for RFA CA 13 001 Funding Number: RFA CA 13 001 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Validation and Advanced Development of Emerging Molecular Analysis Technologies for Cancer Research (R33) Apply for RFA CA 13 002 Funding Number: RFA CA 13 002 Agency: National Institutes of Health Category: Education Health Funding Amount: $300,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 12 290", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.